[go: up one dir, main page]

TR199900506T2 - New methods. - Google Patents

New methods.

Info

Publication number
TR199900506T2
TR199900506T2 TR1999/00506T TR9900506T TR199900506T2 TR 199900506 T2 TR199900506 T2 TR 199900506T2 TR 1999/00506 T TR1999/00506 T TR 1999/00506T TR 9900506 T TR9900506 T TR 9900506T TR 199900506 T2 TR199900506 T2 TR 199900506T2
Authority
TR
Turkey
Prior art keywords
new methods
idoxy
women
post
treatment
Prior art date
Application number
TR1999/00506T
Other languages
Turkish (tr)
Inventor
N. Bradbeer Jeremy
Gowen Maxime
Original Assignee
Smithkline Beecham Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corporation filed Critical Smithkline Beecham Corporation
Publication of TR199900506T2 publication Critical patent/TR199900506T2/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Vascular Medicine (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyrrole Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Post-menopoz dönemindeki kadinlarda kardiyovasküler hastaliklarin tedavisi için yeni bir yöntem tanimlanmaktadir. Tercih edilen bilesim idoksifendir.A new method for the treatment of cardiovascular diseases is described in women in post-menopausal period. The preferred composition is idoxy.

TR1999/00506T 1996-09-06 1997-09-03 New methods. TR199900506T2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US2543996P 1996-09-06 1996-09-06
US5066697P 1997-06-24 1997-06-24

Publications (1)

Publication Number Publication Date
TR199900506T2 true TR199900506T2 (en) 1999-07-21

Family

ID=26699738

Family Applications (2)

Application Number Title Priority Date Filing Date
TR1999/00506T TR199900506T2 (en) 1996-09-06 1997-09-03 New methods.
TR1999/00504T TR199900504T2 (en) 1996-09-06 1997-09-03 Treatment method for postmenopausal diseases, including osteoporosis

Family Applications After (1)

Application Number Title Priority Date Filing Date
TR1999/00504T TR199900504T2 (en) 1996-09-06 1997-09-03 Treatment method for postmenopausal diseases, including osteoporosis

Country Status (16)

Country Link
EP (2) EP0927029A4 (en)
JP (2) JP2002515047A (en)
KR (2) KR20000068472A (en)
CN (2) CN1236299A (en)
AR (1) AR008155A1 (en)
AU (2) AU4247397A (en)
BR (2) BR9711676A (en)
CA (2) CA2264943A1 (en)
CO (2) CO5070658A1 (en)
CZ (1) CZ76699A3 (en)
IL (1) IL128645A0 (en)
NO (2) NO991096D0 (en)
PL (2) PL332278A1 (en)
TR (2) TR199900506T2 (en)
TW (1) TW411273B (en)
WO (2) WO1998009619A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998034608A1 (en) * 1997-02-11 1998-08-13 Novo Nordisk A/S Methods for treatment or prophylaxis of menopausal symptoms
GB9827121D0 (en) * 1998-12-09 1999-02-03 Orion Corp Agent for lowering endothelin levels
DE19905961A1 (en) * 1999-02-12 2000-08-17 Stefan Neubauer Use of estrogens to treat cardiac insufficiency and left ventricular dysfunction following myocardial infarction
US6528681B2 (en) * 2000-04-05 2003-03-04 Bristol-Meyers Squibb Pharma Company Halogenated triphenylethylene derivatives as selective estrogen receptor modulators
TWI303990B (en) 2000-10-17 2008-12-11 Pfizer Prod Inc New use of estrogen agonists/antagonists for improving vascular health

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0260066B1 (en) * 1986-09-11 1990-05-09 National Research Development Corporation Tamoxifen derivatives
KR100326962B1 (en) * 1992-09-15 2002-12-02 메렐 파마슈티칼스 인크. Tamoxifen-Non Metabolic Clomiphene Analog for Treatment of Tolerant Tumor
US5681835A (en) * 1994-04-25 1997-10-28 Glaxo Wellcome Inc. Non-steroidal ligands for the estrogen receptor
US5604248A (en) * 1994-05-05 1997-02-18 Eli Lilly And Company Method for minimizing the uterotrophic effect of tamoxifen and tamoxifen analogs
US5470883A (en) * 1994-05-23 1995-11-28 Stromberg; Brent V. Method of treating peripheral vasoconstriction with tamoxifen citrate
CA2223595C (en) * 1995-06-07 2008-08-05 Neorx Corporation Prevention and treatment of cardiovascular pathologies with tamoxifen analogues
HN1996000101A (en) * 1996-02-28 1997-06-26 Inc Pfizer COMBINED THERAPY FOR OSTEOPOROSIS
US6069175A (en) * 1996-11-15 2000-05-30 Pfizer Inc. Estrogen agonist/antagonists treatment of atherosclerosis

Also Published As

Publication number Publication date
AU4409797A (en) 1998-03-26
BR9711681A (en) 1999-08-24
NO991096L (en) 1999-03-05
EP0929216A1 (en) 1999-07-21
PL332038A1 (en) 1999-08-16
EP0927029A4 (en) 2001-06-13
IL128645A0 (en) 2000-01-31
KR20000068473A (en) 2000-11-25
BR9711676A (en) 1999-08-24
CA2264943A1 (en) 1998-03-12
AR008155A1 (en) 1999-12-09
NO991096D0 (en) 1999-03-05
AU4247397A (en) 1998-03-26
JP2002515047A (en) 2002-05-21
JP2002515046A (en) 2002-05-21
NO991097L (en) 1999-03-05
CN1236299A (en) 1999-11-24
CZ76699A3 (en) 1999-08-11
CO4920218A1 (en) 2000-05-29
CO5070658A1 (en) 2001-08-28
PL332278A1 (en) 1999-08-30
EP0927029A1 (en) 1999-07-07
WO1998009519A1 (en) 1998-03-12
CN1236313A (en) 1999-11-24
TR199900504T2 (en) 1999-06-21
TW411273B (en) 2000-11-11
WO1998009619A1 (en) 1998-03-12
EP0929216A4 (en) 2001-04-04
CA2264775A1 (en) 1998-03-12
NO991097D0 (en) 1999-03-05
KR20000068472A (en) 2000-11-25

Similar Documents

Publication Publication Date Title
EA199700170A1 (en) A METHOD OF OBTAINING SOME AZACYCLOHEXAPETIDES
DE69530701D1 (en) Use of 2,7,8-trimethyl-2- (beta-carboxyethyl) -6-hydroxy-chroman (LLU-alpha)
EP1012795A4 (en) Methods of measuring currency limpness
BG39293A3 (en) METHOD FOR OBTAINING CARBOXYALKYL DIPEPTIDES
DE69722681D1 (en) USE OF ANTI-MICROTUBULI FOR TREATING INFLAMMATABLE COLON DISEASES
DE59608738D1 (en) USE OF EPINASTIN FOR THE TREATMENT OF PAIN
NO975747L (en) Peptidyl heterocycles for use in the treatment of thrombin-related deficiencies
BG101966A (en) Application of 1l-agonist for the treatment of lack of urine retention
BG38334A3 (en) Method for preparing pyrolidinic derivatives
ATE221763T1 (en) THE USE OF GLYCERYLTRIACETATE FOR THE TREATMENT OF ONYCHOMYCOSIS
TR199900506T2 (en) New methods.
DZ2292A1 (en) Method regarding cell immortality.
ATE243036T1 (en) LEVOBUPIVACAIN AND ITS USE AS AN AESTHETIC IN PREGNANT WOMEN
PL318213A1 (en) Method of obtaining 3-(methylothio) propanal
DE69736180D1 (en) TREATMENT OF MANICAL DISEASES
UA19335A (en) Method for preparation of remedy for the treatment of the psoriasis type deseasis
BG37839A3 (en) METHOD FOR OBTAINING ORTHOCONDENSED PYRROLE DERIVATIVES
JPS53107151A (en) Method of dephosphorizing waste water
IT1133899B (en) REFRACTORY LINING FOR LADIES AND PROCEDURE FOR ITS MANUFACTURE
BG29285A3 (en) METHOD FOR THE PREPARATION OF 3-DI-N PROPYLACETOXY BENZODIAZEPIN-2-ONES
DE69526156D1 (en) Use of 1,3-undecadien-5-yne as a fragrance
IL116168A0 (en) Kit for cycle of treatment of osteoporosis
DE3369732D1 (en) Method of determination of human urine kallikrein and kit for the same
SE9300735L (en) starting Blocks
ZA967962B (en) Method for determining the ovulation period of fertile women.